As India and China navigate the balance between diplomacy and potential conflict, Indian businesses are actively seeking to reduce their dependency on Chinese products and investments. Additionally, the China Plus One strategy has emerged as a pivotal approach for multinational corporations (MNCs) looking to diversify their supply chains beyond China. This strategy aims to mitigate [...]
The capital used in the business that is contributed by creditors, shareholders, or owners is measured by the debt-to-equity ratio. The debt-equity ratio, to put it simply, is a ratio of the total amount of long-term debt and equity capital in the company. Here are three pharma stocks with a Debt to Equity ratio of [...]
Dividends represent a portion of a company's profits distributed to its shareholders as a reward for their investment. These regular payments provide investors with a steady income stream and signal a company's financial health and stability. Understanding dividend policies and trends is crucial for investors seeking income and long-term wealth accumulation. Here are the five [...]
Return on capital employed (ROCE) is one of the most important metrics used by investors; it indicates how efficiently a company is managing capital. Generally, ROCE above 15 percent is considered to be good. However, the biggest challenge for companies is to consistently maintain ROCE for years. Along with ROCE, debt on the company also [...]
The players involved in the Pharmaceutical industry, a capital-intensive one, strive hard to maintain average margin ratios such as the net profit margin, atleast matching those of others present in the segment. Listed below are three stocks that have a Net Profit Margin of more than xx percent during FY2022-2023: Caplin Point Laboratories Limited With [...]
Caplin Point Laboratories Ltd shares closed at Rs 950.60 a share, up 1.28 percent on August 4, at a 52-week high of Rs 978.80 and a market capitalization of Rs 7,217 crores. According to BSE data, the stock has delivered multibagger returns of about 72,723 percent over a 14-year period, spanning from Rs 1.30 in [...]
